A nomogram to predict HER2 status in breast cancer patients with HER2-borderline disease as determined via immunohistochemistry

This study aimed to develop a nomogram to predict fluorescence in situ hybridization (FISH) assay results for HER2-borderline breast cancer as determined via immunohistochemistry (IHC) among patients in China. We reviewed a database of breast cancer patients diagnosed between January 2007 and April...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Qianqian, Chen, Kai, Lin, Xiaojie, Su, Yi, Xu, Rui, Dai, Yan, Qiu, Chang, Song, Xue, Mao, Siying, Chen, Qianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706813/
https://www.ncbi.nlm.nih.gov/pubmed/29212167
http://dx.doi.org/10.18632/oncotarget.19313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706813/
https://www.ncbi.nlm.nih.gov/pubmed/29212167
http://dx.doi.org/10.18632/oncotarget.19313

Ejemplares similares